Clinical Usefullness of the Cuffless SOMNOtouch NIBP Device for 24-hour Ambulatory Blood Pressure Measurement
BLAST
1 other identifier
interventional
60
1 country
1
Brief Summary
The SOMNOtouch NIBP is a cuffless device for continuous blood pressure measurement. The device is widely used, but validation for 24-hour ambulatory blood pressure measurement (ABPM) is limited. This study seeks to validate the SOMNOtouch device for use in 24-hour ABMP as compared to a validated oscillometric device for 24-hour ABPM. A total of 60 patients with indication for 24-hour BP measurement will be recruited from our tertiary hypertension Clinic. All included patients will conduct dual 24-hour ABPM with both the SOMNOtouch NIBP and a the oscillometric device. Furthermore, patients will undergo measurement of arterial stiffness with a Sphygmocor device as well as complete a questionaire on device related discomfort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 17, 2020
CompletedFirst Posted
Study publicly available on registry
February 20, 2020
CompletedOctober 2, 2023
September 1, 2023
1.4 years
February 17, 2020
September 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Difference in blood pressure averages between SOMNOtouch NIBP and SPACELABS 90217 / 90207 during 24-hour ABPM
in mmHg
During 24-hour ABPM
Difference in mean systolic blood pressure between SOMNOtouch NIBP and SPACELABS 90217 / 90207 during 24-hour ABPM on the patient level
Bland Altman plots will be used to evaluate accuracy.
During 24-hour ABPM
Difference in mean diastolic blood pressure between SOMNOtouch NIBP and SPACELABS 90217 / 90207 during 24-hour ABPM on the patient level
Bland Altman plots will be used to evaluate accuracy.
During 24-hour ABPM
Secondary Outcomes (3)
The impact of aortic augmentation index normalized to a Heart frequency of 75 beats/minute on BP Measurements with either device.
Aortic augmentation index will be measured prior to 24-hour ABPM.
The impact of pulse wave velocity on BP Measurements with either device.
Pulse Wave velocity will be measured prior to 24-hour ABPM.
Patient satisfaction with SOMNOtouch device compared with the oscillometric device.
Immediately after completion om 24-hour ABPM.
Study Arms (1)
Ambulatory blood pressure measurement
OTHERDual 24-hour ABPM with both the SOMNOtouch NIBP and a validated oscillometric 24-hour ABPM-device (SPACELABS 90217 / 90207).
Interventions
Dual 24-hour ABPM with both the SOMNOtouch NIBP and a validated oscillometric 24-hour ABPM-device (SPACELABS 90217 / 90207).
Eligibility Criteria
You may qualify if:
- Indication for ABPM with an automated oscillometric device
You may not qualify if:
- Known significant arterial abnormalities in the upper extremities
- Known cardiac arrythmia
- Upper arm circumference \>16,5" or \<6", or
- Extreme uncontrolled hypertension (i.e. resting office BP \> 230/140 mmHg).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University Hospital
Aarhus, 8200, Denmark
Related Publications (1)
Nyvad J, Christensen KL, Buus NH, Reinhard M. The cuffless SOMNOtouch NIBP device shows poor agreement with a validated oscillometric device during 24-h ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich). 2021 Jan;23(1):61-70. doi: 10.1111/jch.14135. Epub 2020 Dec 17.
PMID: 33350030DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- When evaluating data quality from either device, PI will be blinded to corresponding BP of the other device.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 17, 2020
First Posted
February 20, 2020
Study Start
September 1, 2018
Primary Completion
February 1, 2020
Study Completion
February 1, 2020
Last Updated
October 2, 2023
Record last verified: 2023-09